According to the Market Statsville Group (MSG), the global hydroxyethyl starch solutions market size is expected to grow at a CAGR of 5.6% from 2023 to 2033.

The HES solutions market is the increasing prevalence of hypovolemia and related conditions. These conditions can be caused by various factors, including surgery, trauma, and sepsis. As a result, the demand for HES solutions is expected to increase as more people are diagnosed with these conditions and require treatment. Another driver of the HES solutions market is the growing number of surgeries and medical procedures performed worldwide. Many surgical procedures require the administration of fluids to maintain proper blood volume and prevent hypovolemia. HES solutions are often used in these situations, and as the number of surgeries and medical procedures increases, so does the demand for HES solutions. The rising demand for minimally invasive surgeries and procedures creates a lucrative growth opportunity for the market. These types of procedures require smaller amounts of fluids, and HES solutions can be particularly useful in these situations due to their ability to expand blood volume quickly.

Global Hydroxyethyl Starch Solutions Market Dynamics

Drivers: Increasing Prevalence of Hypovolemia and Related Conditions

The increasing prevalence of hypovolemia and related conditions is a major driver for the hydroxyethyl starch (HES) solutions market growth. Hypovolemia is a condition characterized by a decreased blood volume, which can lead to a decrease in blood pressure and organ perfusion. This condition can be caused by various of factors, such as trauma, bleeding, sepsis, and surgical procedures, among others. According to data from the World Health Organization (WHO), severe sepsis affects more than 30 million people worldwide each year and is a leading cause of mortality in intensive care units. Additionally, surgical procedures, which often require the administration of intravenous fluids such as HES solutions, are performed on over 300 million people globally each year.

Request Sample Copy of this Report: https://www.marketstatsville.com/request-sample/hydroxyethyl-starch-solutions-market?utm_source=free&utm_medium=harsh           Moreover, certain patient populations are at an increased risk of developing hypovolemia and related conditions, such as older adults and patients with chronic kidney disease. These patients may require intravenous fluids to maintain blood volume and prevent hypovolemia. Therefore, the demand for HES solutions is expected to continue to rise in the forthcoming years. Thus, the increasing prevalence of hypovolemia and related conditions, coupled with the growing number of surgical procedures and vulnerable patient populations, are driving the growth of the HES solutions market. As the demand for these solutions continues to rise, innovations and developments in the field will likely emerge to meet the evolving needs of patients and healthcare providers.

Restraints: Increasing Concern Regarding The Safety and Efficacy of HES Solutions

One of the major restraining factors for the hydroxyethyl starch (HES) solutions market is the increasing concern regarding the safety and efficacy of HES solutions. HES solutions have been linked to several adverse events, such as kidney injury, bleeding, and increased mortality, particularly in patients with sepsis or those undergoing cardiac surgery. In 2013, the European Medicines Agency (EMA) recommended the suspension of the marketing authorization of all HES solutions due to safety concerns, particularly in critically ill patients. Similarly, the US Food and Drug Administration (FDA) issued a safety communication in 2017 warning about the increased risk of mortality and kidney injury associated with HES solutions. Moreover, there is a growing preference for alternative fluid resuscitation strategies, such as crystalloid solutions and albumin, which are considered safer and more cost-effective than HES solutions. Crystalloid solutions are widely available, less expensive, and have fewer associated adverse effects. On the other hand, albumin has been shown to be safe and effective in certain patient populations, such as those with severe sepsis. 

Scope of the Global Hydroxyethyl Starch Solutions Market

The study categorizes the hydroxyethyl starch solutions market based on product type, end-user, and application area at the regional and global levels.

By Product Type Outlook (Sales, USD Million, 2019-2033)

• 6% Hydroxyethyl Starch Solutions
• 10% Hydroxyethyl Starch Solutions
• 20% Hydroxyethyl Starch Solutions
• Others

By Application Outlook (Sales, USD Million, 2019-2033)

• Volume Expansion
• Blood Volume Substitution
• Others

By End-User Outlook (Sales, USD Million, 2019-2033)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

By Region Outlook (Sales, USD Million, 2019-2033)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Italy
  • France
  • UK
  • Spain
  • Poland
  • Russia
  • The Netherlands
  • Norway
  • Czech Republic
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Indonesia
  • Malaysia
  • Thailand
  • Singapore
  • Australia & New Zealand
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Rest of South America
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa
  • Northern Africa
  • Rest of MEA

Direct Purchase Report: https://www.marketstatsville.com/buy-now/hydroxyethyl-starch-solutions-market?opt=3338  

Volume expansion segment accounts for the largest market share by application

Based on the application, the market is divided into volume expansion, blood volume substitution, and others. The volume expansion segment is expected to dominate the market share in 2022 in the global hydroxyethyl starch solutions market. This is primarily due to the widespread use of HES solutions in surgical procedures and critical care settings, where volume expansion is a common therapeutic approach. However, the blood volume substitution segment is also expected to witness significant growth, driven by factors such as the increasing prevalence of hemorrhagic shock and trauma and the development of novel HES solutions with improved efficacy and safety profiles.

North America is expected to witness the largest market share by Region

Based on the regions, the global hydroxyethyl starch solutions market has been segmented across Europe, North America, the Middle East & Africa, Asia-Pacific, and South America. North America is projected to account for the highest market share in 2022 due to factors such as the high prevalence of chronic diseases, increasing surgical procedures, and well-established healthcare infrastructure. Moreover, the presence of several major players in the HES solutions market, such as Fresenius Kabi AG and B. Braun Melsungen AG, further supports the market growth in North America. These companies have significant market shares and continue to invest in research and development to improve the safety and efficacy of HES solutions. Additionally, the increasing focus on patient safety and the growing preference for alternative fluid resuscitation strategies, such as crystalloid solutions and albumin, may present challenges for the HES solutions market in North America.

Competitvie Landscape: Global Hydroxyethyl Starch Solutions Market

The hydroxyethyl starch solutions market is a significant competitor, and extremely cutthroat in the sector are using strategies including product launches, partnerships, acquisitions, agreements, and growth to enhance their market positions. Most sector businesses focus on increasing their operations worldwide and cultivating long-lasting partnerships.

Major key players in the global hydroxyethyl starch solutions market are:

• Skyrun Industrial
• Hangzhou J&H Chemical
• Hefei Hirisun Pharmatech
• AK Scientific
• Carbone Scientific
• Kinbester
• Leap Labchem
• Chengdu Bojia Pharmaceutical
• Company 9
• Company 10
• Company 11
• Company 12
• Company 13
• Company 14
• Company 15

Request For Report Toc: https://www.marketstatsville.com/table-of-content/hydroxyethyl-starch-solutions-market 

Contact US:

Regional Research Reports (RRR)
414 S Reed St, Lakewood,
Colorado, 80226, USA
USA: +1 (646) 663–5829 | +91 702 496 8807
Email: sales@regionalresearchreports.com 
Web: https://www.regionalresearchreports.com/